Coughlin Timothy P Insider Trades

Insider Trading History

Track insider trading activity for Coughlin Timothy P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.34M 29,000 shares
Last Trade
May 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 10,000 shares
$17.94
$46.18
Atyr Pharma
Atyr Pharma LIFE
Director
Holding Value $344k 20,000 shares
Last Trade
May 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 20,000 shares
$8.17
$17.18
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $35.4k 16,000 shares
Last Trade
May 03, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$274k 16,000 shares
$17.15
$2.21
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.25M 27,000 shares
Last Trade
May 09, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 12,500 shares
$26.52
$46.18
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $35.4k 16,000 shares
Last Trade
May 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 16,000 shares
$9.78
$2.21
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.13M 24,500 shares
Last Trade
May 17, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 12,500 shares
$17.44
$46.18
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $55.3k 25,000 shares
Last Trade
May 02, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 25,000 shares
$4.73
$2.21
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $23.1M 137,961 shares
Last Trade
Feb 06, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.5k 963 shares
$43.14
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $22.8M 136,324 shares
Last Trade
Feb 03, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.8k 1,500 shares
$42.55
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $22.6M 134,824 shares
Last Trade
Jan 17, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.1k 1,750 shares
$40.65
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $22.3M 133,124 shares
Last Trade
Jan 10, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$75.9k 1,750 shares
$43.37
$167.35
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $125k 56,390 shares
Last Trade
Nov 23, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$186k 56,390 shares
$3.29
$2.21
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $1.02M 22,000 shares
Last Trade
May 18, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 10,000 shares
$16.33
$46.18
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $55.3k 25,000 shares
Last Trade
May 11, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.3k 25,000 shares
$1.69
$2.21
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $8.12M 48,500 shares
Last Trade
Feb 05, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 79,200 shares
$35.99
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $22M 131,374 shares
Last Trade
Feb 03, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$57.1k 1,500 shares
$38.06
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $21.7M 129,874 shares
Last Trade
Jan 19, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$81.7k 1,750 shares
$46.69
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $21.4M 128,124 shares
Last Trade
Jan 11, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.4k 1,750 shares
$44.25
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $21.1M 126,374 shares
Last Trade
Oct 16, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.19M 25,000 shares
$47.78
$167.35
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $17M 101,374 shares
Last Trade
Jul 20, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.1M 20,000 shares
$55.00
$167.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up